The role of protein arginine-methyltransferase 1 in gliomagenesis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Protein arginine methyltransferase 1 (PRMT1), a type-I arginine methyltransferase, has been implicated in diverse cellular events. We have focused on the role of PRMT1 in gliomagenesis. In this study, we showed that PRMT1 expression was up-regulated in glioma tissues and cell lines compared with normal brain tissues. The knock-down of PRMT1 resulted in an arrest in the G1-S phase of the cell cycle, proliferation inhibition and apoptosis induction in four glioma cell lines (T98G, U87MG, U251, and A172). Moreover, an in vivo study confirmed that the tumor growth in nude mouse xenografts was significantly decreased in the RNAi-PRMT1 group. Additionally,we found that the level of the asymmetric dimethylated modification of H4R3, a substrate of PRMT1, was higher in glioma cells than in normal brain tissues and decreased after PRMT1 knock-down. Our data suggest a potential role for PRMT1 as a novel biomarker of and therapeutic target in gliomas. [BMB Reports 2012; 45(8): 470-475]
Abstract
Protein arginine methyltransferase 1 (PRMT1), a type-I arginine methyltransferase, has been implicated in diverse cellular events. We have focused on the role of PRMT1 in gliomagenesis. In this study, we showed that PRMT1 expression was up-regulated in glioma tissues and cell lines compared with normal brain tissues. The knock-down of PRMT1 resulted in an arrest in the G1-S phase of the cell cycle, proliferation inhibition and apoptosis induction in four glioma cell lines (T98G, U87MG, U251, and A172). Moreover, an in vivo study confirmed that the tumor growth in nude mouse xenografts was significantly decreased in the RNAi-PRMT1 group. Additionally,we found that the level of the asymmetric dimethylated modification of H4R3, a substrate of PRMT1, was higher in glioma cells than in normal brain tissues and decreased after PRMT1 knock-down. Our data suggest a potential role for PRMT1 as a novel biomarker of and therapeutic target in gliomas. [BMB Reports 2012; 45(8): 470-475]
참고문헌 (22)
- Herrmann, F., "Human protein arginine methyltransferases in vivo--distinct properties of eight canonical members of the PRMT family", J. Cell. Sci., 122, pp.667~677 (2009)
- Bedford, M. T., "Arginine methylation an emerging regulator of protein function", Mol. Cell., 18, pp.263~272 (2005)
- Lee, Y. H., "Minireview: protein arginine methylation of nonhistone proteins in transcriptional regulation", Mol. Endocrinol., 23, pp.425~433 (2009)
- Bedford, M. T., "Protein arginine methylation in mammals: who, what, and why", Mol. Cell., 33, pp.1~13 (2009)
- Tang, J., "PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells", J. Biol. Chem., 275, pp.7723~7730 (2000)
- 이진형, "Protein arginine methyltransferases: Evolution and assessment of their pharmacological and therapeutic potential", PHARMACOLOGY THERAPEUTICS, 113(1), pp.50~87, PERGAMON-ELSEVIER SCIENCE LTD
- Pawlak, M. R., "Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable", Mol. Cell. Biol., 20, pp.4859~4869 (2000)
- Yu, Z., "A mouse PRMT1 null allele defines an essential role for arginine methylation in genome maintenance and cell proliferation", Mol. Cell Biol., 29, pp.2982~2996 (2009)
- Huang, S., "Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications", Genes Dev., 19, pp.1885~1893 (2005)
- Wang, H., "Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor", Science, 293, pp.853~857 (2001)
- Lund, A. H., "Epigenetics and cancer", Genes Dev., 18, pp.2315~2335 (2004)
- Nicholson, T. B., "The physiological and pathophysiological role of PRMT1- mediated protein arginine methylation", Pharmacol. Res., 60, pp.466~474 (2009)
- Yoshimatsu, M., "Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers", Int. J. Cancer, 128, pp.562~573 (2011)
- Cho, J. H., "Arginine methylation-dependent regulation of ASK1 signaling by PRMT1", Cell Death. Differ., 19, pp.859~870 (2011)
- Seligson, D. B., "Global histone modification patterns predict risk of prostate cancer recurrence", Nature, 435, pp.1262~1266 (2005)
- Cheung, N., "Protein arginine-methyltransferase- dependent oncogenesis", Nat. Cell. Biol., 9, pp.1208~1215 (2007)
- Furnari, F. B., "Malignant astrocytic glioma: genetics, biology, and paths to treatment", Genes Dev., 21, pp.2683~2710 (2007)
- Wolf, S. S., "The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humans", Cell Mol. Life Sci., 66, pp.2109~2121 (2009)
- Mathioudaki, K., "Clinical evaluation of PRMT1 gene expression in breast cancer", Tumor Biol., 32, pp.575~582 (2011)
- Le Romancer, M., "Methylation, a key step for nongenomic estrogen signaling in breast tumors", Steroids, 75, pp.560~564 (2010)
- Li, X., "H4R3 methylation facilitates -globin transcription by regulating histone acetyltransferase binding and H3 acetylation", Blood, 115, pp.2028~2037 (2010)
- Zhang, Y., "MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a", J. Mol. Med., 87, pp.43~51 (2008)